TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
15,200
|
22,868
|
10,863 |
Financial expenses |
0
|
4
|
2 |
Earnings before taxes |
1,685
|
5,068
|
549 |
EBITDA |
1,620
|
5,095
|
591 |
Total assets |
3,348
|
6,491
|
3,037 |
Current assets |
3,052
|
6,220
|
2,747 |
Current liabilities |
1,866
|
2,428
|
2,595 |
Equity capital |
1,394
|
4,063
|
442 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
65
|
80
|
49 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
41.6%
|
62.6%
|
14.6% |
Turnover per employee |
234
|
286
|
222 |
Profit as a percentage of turnover |
11.1%
|
22.2%
|
5.1% |
Return on assets (ROA) |
50.3%
|
78.1%
|
18.1% |
Current ratio |
163.6%
|
256.2%
|
105.9% |
Return on equity (ROE) |
120.9%
|
124.7%
|
124.2% |
Change turnover |
-5,815
|
12,206
|
-2,084 |
Change turnover % |
-28%
|
114%
|
-16% |
Chg. No. of employees |
-15
|
31
|
2 |
Chg. No. of employees % |
-19%
|
63%
|
4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.